AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives
|
Stroke Main page | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives On the Web | |
|
American Roentgen Ray Society Images of AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives | |
|
FDA on AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives | |
|
CDC on AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives | |
|
AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives in the news | |
|
Blogs on AHA/ASA guideline recommendations for prevention of stroke in women oral contraceptives | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]
2014 AHA/ASA Guideline Recommendations for Prevention of Stroke in Women (DO NOT EDIT)[1]
| Class III (Harm) |
| "1. OCs may be harmful in women with additional risk factors (eg, cigarette smoking, prior thromboembolic events) (Level of Evidence: B) " |
| "2. Routine screening for prothrombotic mutations before initiation of hormonal contraception is not useful. (Level of Evidence: A) " |
| Class I |
| " Measurement of BP before initiation of hormonal contraception is recommended. (Level of Evidence: B) " |
| Class IIb |
| " Among OC users, aggressive therapy of stroke risk factors may be reasonable. (Level of Evidence: C)" |
References
- ↑ Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL; et al. (2014). "Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association". Stroke. doi:10.1161/01.str.0000442009.06663.48. PMID 24503673.